Israel Englander’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-4,000
Closed -$223K 3975
2016
Q3
$223K Buy
+4,000
New +$223K ﹤0.01% 2936
2015
Q1
Sell
-40,000
Closed -$2.31M 4391
2014
Q4
$2.31M Buy
+40,000
New +$1.68M ﹤0.01% 1872

Israel Englander's KITE Position: Q4 2017 in Review

Israel Englander sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 34,394 shares — an estimated $6.18M sold.

Israel Englander first reported a position in KITE in Q2 2015 and held it in 5 quarters. The position peaked at $6.18M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Israel Englander reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Israel Englander sold 34,394 Kite Pharma, Inc. shares in Q4 2017, an estimated $6.18M.
  • Israel Englander first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 5 quarters.
  • Israel Englander's Kite Pharma, Inc. position peaked at $6.18M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.